Nuo Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Nuo Therapeutics, Inc. has filed 1,158 SEC EDGAR filings since 10 Dec 1999

SEC filing history

Showing 126-150 of 790 matching filings.

Per page
25
Current page
6
5

FORM 5

Filing date
26 Apr 2022
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
26 Apr 2022
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5

Filing date
26 Apr 2022
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-32518

FORM NT 10-K

Filing date
31 Mar 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T/A File 005-62061

FINAL AMENDMENT

Filing date
21 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14D9 File 005-62061

SCHEDULE 14D9

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-T File 005-62061

SCHEDULE TO

Filing date
21 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
04 Jan 2022
Reporting date
01 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
21 Apr 2021
Reporting date
20 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-62061

SC 13G filing

Filing date
09 Oct 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
06 Oct 2020
Reporting date
05 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
13 Apr 2020
Reporting date
03 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
30 Mar 2020
Reporting date
30 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
12 Dec 2019
Reporting date
06 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
20 Nov 2019
Reporting date
15 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-32518

FORM NT 10-Q

Filing date
13 Nov 2019
Reporting date
30 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-32518

FORM NT 10-Q

Filing date
14 Aug 2019
Reporting date
30 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
09 Aug 2019
Reporting date
06 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
13 Jun 2019
Reporting date
11 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-32518

FORM NT 10-Q

Filing date
15 May 2019
Reporting date
31 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32518

FORM 8-K

Filing date
07 May 2019
Reporting date
03 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .